GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » ROA %

Lexagene Holdings (Lexagene Holdings) ROA % : -174.68% (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Lexagene Holdings's annualized Net Income for the quarter that ended in Nov. 2022 was $-6.71 Mil. Lexagene Holdings's average Total Assets over the quarter that ended in Nov. 2022 was $3.84 Mil. Therefore, Lexagene Holdings's annualized ROA % for the quarter that ended in Nov. 2022 was -174.68%.

The historical rank and industry rank for Lexagene Holdings's ROA % or its related term are showing as below:

LXXGQ's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -1.84
* Ranked among companies with meaningful ROA % only.

Lexagene Holdings ROA % Historical Data

The historical data trend for Lexagene Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings ROA % Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -167.71 -306.60 -194.96 -103.12 -99.28

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -160.46 -136.22 -117.86 -160.91 -174.68

Competitive Comparison of Lexagene Holdings's ROA %

For the Medical Devices subindustry, Lexagene Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's ROA % falls into.



Lexagene Holdings ROA % Calculation

Lexagene Holdings's annualized ROA % for the fiscal year that ended in Feb. 2022 is calculated as:

ROA %=Net Income (A: Feb. 2022 )/( (Total Assets (A: Feb. 2021 )+Total Assets (A: Feb. 2022 ))/ count )
=-10.62/( (13.195+8.198)/ 2 )
=-10.62/10.6965
=-99.28 %

Lexagene Holdings's annualized ROA % for the quarter that ended in Nov. 2022 is calculated as:

ROA %=Net Income (Q: Nov. 2022 )/( (Total Assets (Q: Aug. 2022 )+Total Assets (Q: Nov. 2022 ))/ count )
=-6.712/( (4.195+3.49)/ 2 )
=-6.712/3.8425
=-174.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Nov. 2022) net income data. ROA % is displayed in the 30-year financial page.


Lexagene Holdings  (OTCPK:LXXGQ) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Nov. 2022 )
=Net Income/Total Assets
=-6.712/3.8425
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.712 / 0.172)*(0.172 / 3.8425)
=Net Margin %*Asset Turnover
=-3902.33 %*0.0448
=-174.68 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) net income data. The Revenue data used here is four times the quarterly (Nov. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Lexagene Holdings ROA % Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (Lexagene Holdings) Headlines

From GuruFocus

LexaGene Closes Secured Convertible Note Transaction

By Value_Insider Value_Insider 11-01-2022

LexaGene Reduces Time-to-Result by ~35%

By PurpleRose PurpleRose 08-10-2022

BioPharma Engages LexaGene in Second Feasibility Study

By Value_Insider Value_Insider 12-16-2022

LexaGene Provides Update on BioPharma Sector

By Stock market mentor Stock market mentor 02-08-2023

LexaGene Announces Management Cease Trade Order

By GlobeNewswire GlobeNewswire 06-30-2022